Evidence map›Paper›PMID 38231498›Full record

ArticleTranslational vision science & technology2024

Visualization of Optic Nerve Structural Patterns in Papilledema Using Deep Learning Variational Autoencoders.

Jui-Kai Ray Wang, Edward F Linton, Brett A Johnson, Mark J Kupersmith, Mona K Garvin, Randy H Kardon

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jui-Kai Ray WangCenter for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
Edward F LintonCenter for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
Brett A JohnsonDepartment of Ophthalmology and Visual Sciences, The University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
Mark J KupersmithDepartments of Neurology, Neurosurgery and Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mona K GarvinCenter for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
Randy H KardonCenter for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA, USA.
University of Iowa Hospitals and Clinics · USIcahn School of Medicine at Mount Sinai · USIowa City VA Health Care System · USUniversity of Iowa · US

Funding

Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision lossR01EY031544 · NEI · UNIVERSITY OF IOWA · PI GRUMBACH, ISABELLA MARIA, KARDON, RANDY H. · 2020 to 2024
$2.8M
3D Image Analysis Approach to Determine Severity and Cause of Optic Nerve EdemaR01EY023279 · NEI · UNIVERSITY OF IOWA · PI GARVIN, MONA K. · 2013 to 2017
$1.7M
Statistical Unsupervised Learning VF for IIHTT & ONTTR21EY032522 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KUPERSMITH, MARK J · 2021 to 2022
$495k
Automated Assessment of Optic Nerve Edema with Low-Cost ImagingI01RX001786 · VA · IOWA CITY VA MEDICAL CENTER · PI GARVIN, MONA K. · 2016 to 2020
–
Early Detection of Progressive Visual Loss in Glaucoma Using Deep LearningI01RX003797 · VA · IOWA CITY VA MEDICAL CENTER · PI GARVIN, MONA K., KARDON, RANDY H. · 2022 to 2025
–
Center for the Prevention and Treatment of Visual LossI50RX003002 · VA · IOWA CITY VA MEDICAL CENTER · PI RANDY H. KARDON, MARKUS H. KUEHN · 2019 to 2026
–
NEI NIH HHS R01 EY023279NEI NIH HHS R01 EY031544NEI NIH HHS R21 EY032522RRD VA I01 RX001786RRD VA I01 RX003797RRD VA I50 RX003002
6 · The paper itself

Abstract

Purpose: To visualize and quantify structural patterns of optic nerve edema encountered in papilledema during treatment. Methods: A novel bi-channel deep-learning variational autoencoder (biVAE) model was trained using 1498 optical coherence tomography (OCT) scans of 125 subjects over time from the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) and 791 OCT scans of 96 control subjects from the University of Iowa. An independent test dataset of 70 eyes from 70 papilledema subjects was used to evaluate the ability of the biVAE model to quantify and reconstruct the papilledema spatial patterns from input OCT scans using only two variables. Results: The montage color maps of the retinal nerve fiber layer (RNFL) and total retinal thickness (TRT) produced by the biVAE model provided an organized visualization of the variety of morphological patterns of optic disc edema (including differing patterns at similar thickness levels). Treatment effects of acetazolamide versus placebo in the IIHTT were also demonstrated in the latent space. In image reconstruction, the mean signed peripapillary retinal nerve fiber layer thickness (pRNFLT) difference ± SD was -0.12 ± 17.34 µm, the absolute pRNFLT difference was 13.68 ± 10.65 µm, and the RNFL structural similarity index reached 0.91 ± 0.05. Conclusions: A wide array of structural patterns of papilledema, integrating the magnitude of disc edema with underlying disc and retinal morphology, can be quantified by just two latent variables. Translational Relevance: A biVAE model encodes structural patterns, as well as the correlation between channels, and may be applied to visualize individuals or populations with papilledema throughout treatment.

Indexed as

Deep LearningPapilledemaEdemaHumansOptic NerveRetina

Identifiers

PMID38231498
PMCPMC10795546
OpenAlexW4390940234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.